Invigorating Qi

"Invigorating Qi" (or Bu Qi) is a fundamental therapeutic principle in Traditional Chinese Medicine (TCM) rather than a specific molecular target such as a protein, receptor, or enzyme (Source: NIH/NCCIH). It refers to the pharmacological action of replenishing the body's vital energy to treat "Qi deficiency," a state characterized by chronic fatigue, muscle weakness, and impaired organ function (Source: PubMed 25444558). While it does not represent a single target, modern research has mapped this physiological effect to several biological pathways, most notably the enhancement of mitochondrial function and ATP synthesis, the stabilization of the hypothalamic-pituitary-adrenal (HPA) axis, and the modulation of the immune system (Source: PMC 6073404). Agents that "invigorate Qi," such as Panax ginseng or Astragalus membranaceus, contain bioactive compounds like ginsenosides and polysaccharides that interact with multiple cellular pathways rather than a single receptor (Source: PMC 5758356). These compounds are often studied for their adaptogenic properties, helping the body resist physical, chemical, and biological stressors. In clinical drug development, the components of Qi-tonifying formulas are evaluated for their synergistic effects on metabolic and immune homeostasis. Consequently, "Invigorating Qi" is classified as an incorrect molecular target because it describes a complex physiological outcome or therapeutic category rather than a discrete biological entity suitable for standard high-throughput screening or target-based drug design.

Other names

Qi-tonifyingBu QiTonifying QiSpleen-Qi invigoratingReplenishing Qi

Modulation of mitochondrial respiratory chain activity to increase ATP production, regulation of the hypothalamic-pituitary-adrenal (HPA) axis, and enhancement of cytokine production (e.g., IL-2, IFN-gamma) to boost immune surveillance.